Variables | All patients | Q1 | Q2 | Q3 | Q4 | P |
---|---|---|---|---|---|---|
(n = 567) | (n = 142) | (n = 142) | (n = 142) | (n = 141) | ||
Baseline characteristics | ||||||
Age, mean (SD), years | 58.7 ± 10.9 | 58.5 ± 10.2 | 58.4 ± 10.4 | 58.8 ± 10.7 | 59.0 ± 12.2 | 0.967 |
Sex, male, n (%) | 336 (59.3%) | 77 (54.2%) | 100 (70.4%) | 84 (59.2%) | 75 (53.2%) | 0.012* |
BMI, mean (SD), kg/m2 | 22.8 ± 3.3 | 24.3 ± 3.1 | 23.5 ± 3.0 | 22.5 ± 3.1 | 20.7 ± 2.9 | < 0.001* |
BMI ≥ 25 kg/m2, n (%) | 134 (23.6%) | 53 (37.3%) | 39 (27.5%) | 29 (20.4%) | 13 (9.2%) | < 0.001* |
Comorbidities | ||||||
Smoking history, n (%) | 214 (37.7%) | 48 (33.8%) | 64 (45.1%) | 56 (39.4%) | 46 (32.6%) | 0.116 |
Alcohol intake, n (%) | 179 (31.6%) | 44 (31%) | 55 (38.7%) | 40 (28.2%) | 40 (28.4%) | 0.184 |
Hypertension, n (%) | 168 (29.6%) | 53 (37.3%) | 46 (32.4%) | 43 (30.3%) | 26 (18.4%) | 0.004* |
Diabetes mellitus, n (%) | 128 (22.6%) | 35 (24.6%) | 34 (23.9%) | 31 (21.8%) | 28 (19.9%) | 0.765 |
Coronary artery disease, n (%) | 44 (7.8%) | 12 (8.5%) | 9 (6.3%) | 15 (10.6%) | 8 (5.7%) | 0.417 |
Preoperative characteristics | ||||||
Abdominal surgery history, n (%) | 164 (28.9%) | 38 (26.8%) | 39 (27.5%) | 36 (25.4%) | 51 (36.2%) | 0.176 |
Lesion site, pancreas, n (%) | 356 (62.8%) | 90 (63.4%) | 90 (63.4%) | 91 (64.1%) | 85 (60.3%) | 0.913 |
ASA classification | 0.652 | |||||
Class I–II, n (%) | 477 (84.1%) | 120 (84.5%) | 122 (85.9%) | 121 (85.2%) | 114 (80.9%) | |
Class III, n (%) | 90 (15.9%) | 22 (15.5%) | 20 (14.1%) | 21 (14.8%) | 27 (19.1%) | |
Pre-ALB, mean (SD), g/L | 40 ± 4.8 | 40.9 ± 4.4 | 40.1 ± 4.3 | 39.6 ± 4.9 | 39.3 ± 5.3 | 0.020* |
Pre-ALB < 35 g/L, n (%) | 78 (13.8%) | 10 (7%) | 12 (8.5%) | 25 (17.6%) | 31 (22%) | < 0.001* |
Pre-TBIL, median (IQR), μmol/L | 18.6 (11.4 ~ 69.5) | 17.9 (11.5 ~ 67.7) | 18.8 (11.8 ~ 72.9) | 19.6 (11.3 ~ 64.9) | 18.5 (11.1 ~ 88.8) | 0.918 |
Pre-TBIL > 17.1 μmol/L, n (%) | 303 (53.4%) | 74 (52.1%) | 75 (52.8%) | 78 (54.9%) | 76 (53.9%) | 0.967 |
Pre-GLU, mean (SD), mmol/L | 6.5 ± 2.4 | 6.4 ± 2.2 | 6.5 ± 2.0 | 6.8 ± 2.9 | 6.5 ± 2.4 | 0.384 |
Pre-GLU > 6 mmol/L, n (%) | 244 (43.0%) | 57 (40.1%) | 69 (48.6%) | 61 (43%) | 57 (40.4%) | 0.446 |
Preoperative fluid infusion, n (%) | 200 (35.3%) | 32 (22.5%) | 42 (29.6%) | 55 (38.7%) | 71 (50.4%) | < 0.001* |
Intraoperative characteristics | ||||||
TIVA, n (%) | 50 (8.8%) | 11 (7.7%) | 9 (6.3%) | 9 (6.3%) | 21 (14.9%) | 0.030* |
Surgery time, mean (SD), h | 5.9 ± 1.4 | 5.9 ± 1.3 | 6.0 ± 1.4 | 5.9 ± 1.4 | 5.7 ± 1.4 | 0.273 |
PPPD, n (%) | 76 (13.4%) | 20 (14.1%) | 24 (16.9%) | 20 (14.1%) | 12 (8.5%) | 0.211 |
Blood transfusion, n (%) | 301 (53.1%) | 40 (28.2%) | 64 (45.1%) | 84 (59.2%) | 113 (80.1%) | < 0.001* |
Blood loss, median (IQR), L | 0.5 (0.3 ~ 0.7) | 0.4 (0.3 ~ 0.6) | 0.4 (0.3 ~ 0.7) | 0.4 (0.3 ~ 0.8) | 0.5 (0.4 ~ 0.9) | 0.006* |
RBC, median (IQR), units | 0 (0 ~ 3) | 0 (0 ~ 0) | 0 (0 ~ 2) | 2 (0 ~ 2) | 4 (1 ~ 4) | < 0.001* |
FFP, median (IQR), L | 0 (0 ~ 0.4) | 0 (0 ~ 0.05) | 0 (0 ~ 0.4) | 0.2 (0 ~ 0.4) | 0.4 (0 ~ 0.4) | < 0.001* |
Crystalloid, median (IQR), L | 3 (2.4 ~ 3.7) | 2.45 (2.1 ~ 2.7) | 2.85 (2.5 ~ 3.4) | 3.3 (2.7 ~ 3.9) | 3.4 (2.8 ~ 4.3) | < 0.001* |
Colloid, median (IQR), L | 1 (0.5 ~ 1) | 0.5 (0.5 ~ 1) | 1 (0.5 ~ 1) | 1 (0.5 ~ 1) | 1 (0.5 ~ 1.5) | < 0.001* |